Nasdaq
CMPX
Compass Therapeutics, Inc.
- Health Care
- 1 day
- +5.3%
- 1 month
- −14.2%
- 1 year
- −31.6%
$1.99 · Mkt cap $358M
At the 6 Aug 2026 close
Nasdaq
Compass Therapeutics, Inc.
$1.99 · Mkt cap $358M
At the 6 Aug 2026 close
Compass Therapeutics, Inc. trades under the ticker CMPX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $358M. The last closing price was $1.99, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −31.6%, and −14.2% over the past month. Returns are price returns and exclude dividends.
This page exists because CMPX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.